Business
Proposed Retail Offer
Genedrive PLC announced a retail offer to issue new ordinary shares at a price of 0.20 pence per share. This retail offer is part of a larger fundraising effort that includes a placing of new ordinary shares. Subscribers in the Fundraising will receive one warrant for every one Ordinary Share subscribed for, with each warrant entitling the holder to acquire one new Ordinary Share at a price of 0.40 pence. The company is targeting a retail offer raise of £0.3 million, with the ability to increase this to up to 10 per cent. of the Placing following the close of the Bookbuild. The retail offer opens on 23 September 2025 and is expected to close on 26 September 2025, with admission of the new ordinary shares expected on 16 October 2025. Disclaimer*
About this update from Genedrive Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\n \nTHE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION HAS NOT BEEN APPROVED FOR THE PURPOSES OF SECTION 21 OF HE FINANCIAL SERVICES AND MARKETS ACT 2000 (AS AMENDED) AND IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF GENEDRIVE PLC). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY BY SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF GENEDRIVE PLC.\n \n23 September 2025\n \ngenedrive plc\n \n(\"genedrive\", the \"Group\" or the \"Company\")\n \nProposed Retail Offer\n \nManchester, UK - 23 September 2025: genedrive plc (LSE: GDR), the point of care pharmacogenetic testing company, announces a retail offer via BookBuild (the \"Retail Offer\") of new ordinary shares of 0.015 pence each (\"Ordinary Shares\") in the capital of the Company (the \"Retail Offer Shares\") at an issue price of 0.20 pence per new Ordinary Share (as defined below) (the \"Issue Price\").\n \nIn addition to the Retail Offer, the Company is also conducting a placing of new ordinary shares (the \"Placing Shares\" and together with the Retail Offer Shares, the \"New Ordinary Shares\") at the Issue Price (the \"Placing\" and together with the Retail Offer, the \"Issue\" or the \"Fundraising\").\n \nA separate announcement has been made today with details of the Placing and its terms and conditions as well as setting out the background to the Fundraising and the u...